|

|
A Prozac Moment in Privacy and Marketing
Stephen Cobb, CISSP
A few years ago, when someone broke into the Western Union web
site and compromised about 15,000 credit cards, including one of
mine, it was described by the press as a "security incident."
A couple of months ago, when the press reported that 8 million credit
cards had been compromised, it was called a "privacy incident."
This subtle shift in language underlines a major shift in consumer
perception. When incidents occur that result is the exposure of
personally identifiable information-known in privacy circles as
PII-the media will pounce, the public will take notice, and any
individual who feels they suffered as a result of the exposure will
find the lawyers lining up to take their case.
This shift in perception is unfortunate for many reasons, not least
of which is the fact that many of these incidents could be avoided
if companies would pay closer attention to time-honored business
practices. For example, using disciplined software development methods
and quality assurance controls can go a long way to ensuring the
protection of customer PII. Indeed, the first really big privacy
incident of this century, the so-called "Eli Lilly Prozac Email
Incident" was a case of software development and quality assurance
gone wrong (I know because I assisted the Federal Trade Commission
with its investigation of, and ensuing settlement with, Eli Lilly;
however, nothing in this article is privileged information-it is
all there in the public documents at www.ftc.gov).
Some readers may be familiar with this particular incident, but
a surprising number of people are not. For example, a few weeks
ago my company presented a series of privacy seminars for a different
but equally large pharmaceutical company. To our surprise, less
than a third of those attending were aware of the facts of this
case, so they obviously bear repeating. Here they are, in the words
of the FTC (the term "respondent" refers to Eli Lilly,
and "Medi-messenger" is an email reminder service that
the company promoted at Prozac.com):
"On June 27, 2001, at respondent's direction, an Eli Lilly
employee sent an email message to Medi-messenger subscribers announcing
the termination of the Medi-messenger service. To do this, the employee
created a new computer program to access subscribers' email addresses
and send them the email. The June 27th email disclosed the email
addresses of all 669 Medi-messenger subscribers to each individual
subscriber by including all of the recipients' email addresses within
the "To:" line of the message. By including the email
addresses of all Medi-messenger subscribers within the June 27th
email message, respondent unintentionally disclosed personal information
provided to it by consumers in connection with their use of the
Prozac.com Web site."
You might wonder how this could happen. Surely a company like Eli
Lilly has a comprehensive set of information security policies,
proper software development procedures, and a software quality assurance
program. In fact, Eli Lilly had all of these. For example, there
was a policy that said no code was to be put into production without
adequate testing and supervisor approval. But here's the rub, something
you will see in a lot of other companies: those rules were applied
mainly to the IT department, the folks who grew out of the mainframe,
in-house data processing departments of yore. Those rules had not
been applied consistently to the Internet team, the fast-moving,
fleet-footed, code-for-the-moment folks who brought you the corporate
web site. And who manages email? In many companies, it's those same
Internet folks, who may not be accustomed to, or feel bound by,
standard IT safeguards and protocols. Here is more of what the FTC
said:
"The June 27th disclosure of personal information resulted
from respondent's failure to maintain or implement internal measures
appropriate under the circumstances to protect sensitive consumer
information. For example, respondent failed to provide appropriate
training for its employees regarding consumer privacy and information
security; failed to provide appropriate oversight and assistance
for the employee who sent out the email, who had no prior experience
in creating, testing, or implementing the computer program used;
and failed to implement appropriate checks and controls on the process,
such as reviewing the computer program with experienced personnel
and pretesting the program internally before sending out the email.
Respondent's failure to implement appropriate measures also violated
certain of its own written policies."
There are numerous lessons to learned here, especially if your
company wants to avoid hefty fines and twenty years of government
oversight (which were the consequences for Eli Lilly). First of
all, companies need to make sure that there are strict rules for
software development, and that everyone doing software development
is playing by them (simply having rules was not a defense as far
as the FTC was concerned).
The second lesson is that all employees need to be made aware of
the company's privacy policies (assuming you have these properly
documented). Today's smart companies are making sure that every
employee who deals with customer PII, even the folks in IT, whom
you might not think of as "customer" people, are aware
of just what a big deal it is to breach the privacy promises that
the company has made to its customers. Any transgressions the come
to the attention of management should be addressed (this may not
mean firing people-but if you don't enforce a policy it is legally
useless in your defense).
The third lesson, from this and other recent incidents is that
bad news can have a cumulative effect. For example, less than six
months after Eli Lilly reached a settlement with the FTC over the
prozac.com privacy problem, the company was accused of another Prozac-related
privacy violation. This second case involved samples of Prozac which
were mailed to people in Florida, through a marketing deal involving-allegedly-the
recipient's physician, the recipient's pharmacist, and Eli Lilly
sales reps. Reporters writing about this incident took the opportunity
to remind people of the company's troubles with the FTC over the
earlier Prozac-related privacy incident.
The fourth lesson is that marketing is probably the "hot spot"
for privacy of customer information. Both Lilly incidents were related
to marketing efforts, as was the Ziff Davis Media case, which cost
the company six figures in fines last year. The potential for marketing
via the Internet is so enormous, and the perceived cost-of-entry
so low, it is understandably difficult for marketing folks to resist
the urge to rush out and put up a web site or send out a zillion
emails. But if something goes wrong, your company could be paying
hundreds of thousands of dollars to fix it, money that would have
been far better spent doing it right the first time.
Stephen Cobb is the author of "Privacy for Business: Web Sites
and Email" (www.privacyforbusiness.com) and Senior VP of Research
and Education for ePrivacy Group (www.eprivacygroup.com). Together
with his wife, Chey, who is also a Certified Information System
Security Professional, Stephen advises companies on matters of privacy
and security, and teaches graduate courses in Information Assurance
at Norwich University, Vermont. The Cobb's weekly column on security
can be read at Newsscan.com. Stephen can reached at scobb@cobb.com.
About the Author
A Certified Information System Security Professional since 1996,
Stephen Cobb is the author of Privacy
for Business: Web Sites and Email. and Senior VP of Research
and Education at ePrivacy
Group. Stephen also teaches on the Master
of Science in Information Assurance program at Norwhich University,
Vermont. You can email him at scobb at eprivacygroup.com.
Copyright Stephen Cobb, 2003.
|
|